|
|
||||||||
Nutrition |
dem Altay3
1 Department of Clinical Biochemistry, NBG, AS, and2
Department of Clinical Biochemistry, Aalborg Hospital, Aarhus University Hospital, Aarhus, Denmark.
3 Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
aAddress correspondence to this author at: Department of Clinical Biochemistry, NBG, AS, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus C, Denmark. Fax 45-89493060; e-mail vakurbor{at}hotmail.com.
Background: Current tests for evaluation of vitamin B12 absorption are problematic because they involve the use of radioactively labeled vitamin B12. We describe a vitamin B12 absorption test that circumvents this problem.
Methods: We measured cobalamin or transcobalamin saturated with cobalamin (holo-TC) 24 h after three 9-µg doses of vitamin B12 given orally at 6-h intervals. We studied 17 patients with inherited malabsorption of vitamin B12 attributable to ImerslundGrasbeck syndrome (n = 13) or intrinsic factor deficiency (n = 4), their obligate heterozygous biological parents (n = 19), and healthy controls (n = 44).
Results: In the patients, the median (range) change of holo-TC after the B12 load was not significant [1 (42 to 5) pmol/L], nor was the change of cobalamin [3 (32 to 22) pmol/L], consistent with a lack of measurable active or passive absorption. In controls, however, the median (range) increases of holo-TC and cobalamin were 26 (6 to 63) pmol/L and 41 (37 to 109) pmol/L, respectively. Similarly, the parents showed increases of 23 (2 to 47) pmol/L and 27 (15 to 94) pmol/L. The mean areas under the ROC curves (95% confidence intervals) were 0.97 (0.931.0) for holo-TC and 0.87 (0.790.94) for cobalamin, distinguishing patients from controls. At a cutoff of 6 pmol/L for holo-TC, the diagnostic sensitivity (95% confidence interval) was 100 (81100)%, and the diagnostic specificity was 92 (8297)%.
Conclusion: Measurement of holo-TC after administration of vitamin B12 is a promising approach for evaluating vitamin B12 absorption.
The following articles in journals at HighWire Press have cited this article:
![]() |
R. Clarke, P. Sherliker, H. Hin, E. Nexo, A. M. Hvas, J. Schneede, J. Birks, P. M. Ueland, K. Emmens, J. M. Scott, et al. Detection of Vitamin B12 Deficiency in Older People by Measuring Vitamin B12 or the Active Fraction of Vitamin B12, Holotranscobalamin Clin. Chem., May 1, 2007; 53(5): 963 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M von Castel-Roberts, A. L. Morkbak, E. Nexo, C. A Edgemon, D. R Maneval, J. J Shuster, J. F Valentine, G. P. Kauwell, and L. B Bailey Holo-transcobalamin is an indicator of vitamin B-12 absorption in healthy adults with adequate vitamin B-12 status Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1057 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Carkeet, S. R. Dueker, J. Lango, B. A. Buchholz, J. W. Miller, R. Green, B. D. Hammock, J. R. Roth, and P. J. Anderson Human vitamin B12 absorption measurement by accelerator mass spectrometry using specifically labeled 14C-cobalamin PNAS, April 11, 2006; 103(15): 5694 - 5699. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Miller, M. G. Garrod, A. L. Rockwood, M. M. Kushnir, L. H. Allen, M. N. Haan, and R. Green Measurement of Total Vitamin B12 and Holotranscobalamin, Singly and in Combination, in Screening for Metabolic Vitamin B12 Deficiency Clin. Chem., February 1, 2006; 52(2): 278 - 285. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |